ATTACKPOINT DISCOVERY
LIVE

Serial Number

79439112

Owner

Contera Pharma A/S

Filing Date

Aug 29, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ATTACKPOINT DISCOVERY Trademark

Serial Number: 79439112

ATTACKPOINT DISCOVERY is a trademark filed by Contera Pharma A/S on August 29, 2025. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Contera Pharma A/S (5 trademarks)

Venlighedsvej 4

Entity Type: 24

Trademark Details

Filing Date

August 29, 2025

Registration Date

Not Registered

Goods & Services

Research and development services in the field of pharmaceuticals and drug discovery; development of processes and methods for medical and veterinary purposes; development of preparations for medical and veterinary purposes; scientific research for medical purposes, namely, screening for the identification of drug candidates; development of precision RNA therapeutics; development of tailored RNA-based corrective interventions to target the root causes of serious diseases; research and development of new medical products for others; development and identification of novel druggable sites for pharmacological intervention using a bioinformatic discovery platform in a wet lab; screening services, bioinformatics services and modelling services to harness natural processes and modulate gene expression through platforms to generate optimized small molecules, antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs).

Filing History

REFUSAL PROCESSED BY IB
Mar 12, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 20, 2026 RFCS
REFUSAL PROCESSED BY MPU
Feb 19, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 24, 2026 RFCR
NON-FINAL ACTION WRITTEN
Jan 23, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 13, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 14, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 14, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 11, 2025 REPR